New UK Clinical Trial

  1. 37 Posts.
    lightbulb Created with Sketch. 5
    Invex Therapeutics (ASX:IVX)
    Invex has received an approval from the UK’s MHRA to commence its IIH EVOLVE Phase III clinical trial in the country. The trial will study patients with Idiopathic Intracranial Hypertension (IIH), and they will be randomly treated with Presendin versus placebo once weekly over 24 weeks.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.6¢
Change
0.000(0.00%)
Mkt cap ! $8.199M
Open High Low Value Volume
9.6¢ 9.6¢ 9.6¢ $544 5.668K

Buyers (Bids)

No. Vol. Price($)
3 52756 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 146502 2
View Market Depth
Last trade - 13.48pm 07/08/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.